PR Newswire - New Nature Communications Publication Highlights E...
HONG KONG, May 13, 2026 /PRNewswire/ -- A major new clinical study, SUPER 2, has been published in Nature Communications, reporting that Efsubaglutide Alfa, a long-acting GLP-1 receptor agonist, signi...
Read More

ภาษาไทย
English